The federal government has committed significant funds toward biodefense and pandemic preparedness: the NIH budget for biodefense -- over $1.5 billion annually for the last several years; Project BioShield -- $5.6 billion over 10 years for biodefense products; HHS -- $6.1 billion for pandemic preparedness in FY 2006 and FY 2007 combined; and the Department of Defense continues to invest heavily. This session will inform participants of the current and future business opportunities in biodefense and pandemic preparedness and how to do business with the federal government.



Objectives:

Provide an overview of current and future opportunities and priorities in federal programs related to biodefense and pandemic preparedness, including research and development and product acquisition.

Provide a practical approach to doing business with the federal government. Understand the "nuts and bolts" of the federal programs, who the key offices and decision makers are, and how to learn about and respond to opportunities.

Present an overview of policy issues, which heavily influence federal contracting opportunities.